A therapy app to help with itch from skin conditions
Part of Immune system & allergy, Skin clinical trials.
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed by a doctor with psoriasis, eczema, or long-lasting hives (chronic urticaria).
- You are 16 years old or older.
- Your worst itch in the past 24 hours is at least a 4 on a 0–10 scale (0 = no itch, 10 = worst imaginable itch).
- You can read and use a smartphone app in English.
- You do not have active or unstable mental health symptoms (such as suicidal thoughts or psychosis) or had a mental health hospital stay or started a new psychiatric medication in the last 3 months.
- Your skin condition has not flared up in the last 2 weeks (e.g., you haven't needed steroids, oral antibiotics, or other urgent treatments), and you have not started new phototherapy or systemic medications in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new smartphone app that measures how red your psoriasis patches are by analyzing photos. It aims to help doctors track psoriasis severity more easily from home, without frequent clinic visits.
This study tests a digital mindfulness program to help teens manage their eczema. It looks at whether this approach can reduce symptoms and improve quality of life.
This study tests a new lotion and tablet combination for treating mild to moderate itching and hives in people with dry or sensitive skin. You'll use the products at home and have regular check-ins to see if they're safe and effective.
This trial tests a new way to schedule follow-up appointments for skin clinic patients using online questionnaires. It may help reduce unnecessary visits and make care more convenient.
This study tests a new sensor that monitors skin inflammation using gentle vibrations. It aims to see if this sensor can track how well phototherapy (light treatment) works for eczema or psoriasis.
This study tests whether roflumilast cream (a new anti-inflammatory medication applied to the skin) can reduce the intense itching caused by atopic dermatitis (eczema). You'll track your itching daily using a smartphone app and visit the clinic to see if the cream helps over time.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.